| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |